Treatment of localized extranodal NK/T cell lymphoma, nasal type

International Journal of Hematology

Volumn 92, Issue 5, 2010, Pages 690-696

  Kim, Seok Jin ^a   Kim, Won Seog ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Extranodal NK T cell lymphoma; Localized disease; Treatment

Indexed keywords

ASPARAGINASE; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISOLONE; PREDNISONE; PROCARBAZINE; SEMUSTINE; VINCRISTINE;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASE; CHEMORADIOTHERAPY; HIGH RISK POPULATION; HUMAN; MULTIPLE CYCLE TREATMENT; NK T CELL LYMPHOMA; PROGNOSIS; RADIATION DOSE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

DRUG THERAPY; HUMANS; LYMPHOMA, EXTRANODAL NK-T-CELL; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; SALVAGE THERAPY; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 78751591536     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0720-8     Document Type: Article

References (46)

1. NL Harris ES Jaffe J Diebold G Flandrin HK Muller-Hermelink J Vardiman, et al. 1999 World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997 J Clin Oncol 17 3835 3849 1:STN:280:DC%2BD3c%2FksVyltQ%3D%3D 10577857
2. ES Jaffe JK Chan IJ Su G Frizzera S Mori AC Feller, et al. 1996 Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology Am J Surg Pathol 20 103 111 1:STN:280:DyaK287jtVahug%3D%3D 8540601 10.1097/00000478- 199601000-00012
3. P Kanavaros MC Lescs J Briere M Divine F Galateau I Joab, et al. 1993 Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus Blood 81 2688 2695 1:STN:280: DyaK3s3lslKqsg%3D%3D 8387835
4. WY Au DD Weisenburger T Intragumtornchai S Nakamura WS Kim I Sng, et al. 2009 Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the international peripheral T-cell lymphoma project Blood 113 3931 3937 1:CAS:528:DC%2BD1MXlsVWrsLs%3D 19029440 10.1182/blood-2008-10-185256
5. K Oshimi K Kawa S Nakamura R Suzuki J Suzumiya M Yamaguchi, et al. 2005 NK-cell neoplasms in Japan Hematology. 10 237 245 16019472 10.1080/ 10245330400026162
6. WS Kim SY Song YC Ahn YH Ko CH Baek DY Kim, et al. 2001 CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol 12 349 352 1:STN:280:DC%2BD3MrhsFCjtQ%3D%3D 11332147 10.1023/A:1011144911781
7. BS Kim TY Kim CW Kim JY Kim DS Heo YJ Bang, et al. 2003 Therapeutic outcome of extranodal NK/T-cell lymphoma initially treated with chemotherapy-result of chemotherapy in NK/T-cell lymphoma Acta Oncol 42 779 783 1:CAS:528:DC%2BD3sXls1Cnur4%3D 14690165 10.1080/02841860310010682
8. B Wang JJ Lu X Ma Y Guo H Lu X Hong, et al. 2007 Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity Leuk Lymphoma 48 396 402 17325902 10.1080/10428190601059795
9. SJ Kim BS Kim CW Choi HY Seo HR Seol HJ Sung, et al. 2006 Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract Leuk Lymphoma 47 1265 1273 1:CAS:528:DC%2BD28XhtFWksbrL 16923556 10.1080/10428190500331626
10. SH Lee YC Ahn WS Kim YH Ko K Kim K Park 2006 The effect of pre-irradiation dose intense CHOP on anthracycline resistance in localized nasal NK/T-cell lymphoma Haematologica 91 427 428 16503553
11. TM Kim SY Lee YK Jeon BY Ryoo GJ Cho YS Hong, et al. 2008 Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group Ann Oncol 19 1477 1484 1:STN:280: DC%2BD1cvotlertw%3D%3D 18385201 10.1093/annonc/mdn147
12. GE Kim SW Lee SK Chang HC Park HR Pyo JH Kim, et al. 2001 Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck Radiother Oncol 61 261 269 1:STN:280:DC%2BD3MnosFKguw%3D%3D 11730995 10.1016/S0167-8140(01)00428-5
13. MM Cheung JK Chan WH Lau RK Ngan WW Foo 2002 Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality Int J Radiat Oncol Biol Phys 54 182 190 12182990
14. JY You KH Chi MH Yang CC Chen CH Ho WK Chau, et al. 2004 Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan Ann Oncol 15 618 625 15033670 10.1093/annonc/mdh143
15. K Kim EK Chie CW Kim IH Kim CI Park 2005 Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy Jpn J Clin Oncol 35 1 5 1:CAS:528:DC%2BD2MXltVeqtb4%3D 15681596 10.1093/jjco/hyi006
16. YX Li B Yao J Jin WH Wang YP Liu YW Song, et al. 2006 Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma J Clin Oncol 24 181 189 16382127 10.1200/JCO.2005.03.2573
17. MJ Huang Y Jiang WP Liu ZP Li M Li L Zhou, et al. 2008 Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract Int J Radiat Oncol Biol Phys 70 166 174 17919841 10.1016/j.ijrobp.2007.05.073
18. R Suzuki K Takeuchi K Ohshima S Nakamura 2008 Extranodal NK/T-cell lymphoma: diagnosis and treatment cues Hematol Oncol 26 66 72 18283711 10.1002/hon.847
19. H Kohrt R Advani 2009 Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment Leuk Lymphoma 50 1773 1784 1:CAS:528:DC%2BD1MXhsFOlsrbF 19883307 10.3109/10428190903186502
20. R Liang 2009 Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type Br J Haematol 147 13 21 1:CAS:528: DC%2BD1MXhtlWltbbM 19604234 10.1111/j.1365-2141.2009.07802.x
21. TM Kim DS Heo 2009 Extranodal NK/T-cell lymphoma, nasal type: new staging system and treatment strategies Cancer Sci 100 2242 2248 1:CAS:528: DC%2BD1MXhsFOltrvO 19758393 10.1111/j.1349-7006.2009.01319.x
22. V Ribrag M Ell Hajj F Janot T Girinsky C Domenge G Schwaab, et al. 2001 Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx Leukemia 15 1123 1126 1:STN:280:DC%2BD3MvgsFCjsw%3D%3D 11455983 10.1038/sj.leu.2402148
23. M Yamaguchi K Kita H Miwa K Nishii K Oka T Ohno, et al. 1995 Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells Cancer 76 2351 2356 1:STN:280:DyaK283itlaqsw%3D%3D 8635042 10.1002/1097-0142(19951201)76: 11<2351::AID-CNCR2820761125>3.0.CO;2-1
24. JS Chen KH Lin DT Lin RL Chen ST Jou IJ Su 1998 Longitudinal observation and outcome of nonfamilial childhood haemophagocytic syndrome receiving etoposide-containing regimens Br J Haematol 103 756 762 1:CAS:528: DyaK1MXhslKgsw%3D%3D 9858227 10.1046/j.1365-2141.1998.01026.x
25. M Uno J Tsuchiyama A Moriwaki T Noguchi K Mizoguchi T Ogino, et al. 2001 In vitro induction of apoptosis for nasal angiocentric natural killer cell lymphoma-derived cell line, NK-YS, by etoposide and cyclosporine A Br J Haematol 113 1009 1014 1:CAS:528:DC%2BD3MXlslalsbc%3D 11442496 10.1046/j.1365-2141.2001. 02844.x
26. KW Lee T Yun DW Kim SA Im TY Kim SS Yoon, et al. 2006 First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy ± radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma Leuk Lymphoma 47 1274 1282 1:CAS:528:DC%2BD28XhtFWksbrE 16923557 10.1080/10428190600562823
27. M Yamaguchi K Tobinai M Oguchi N Ishizuka Y Kobayashi Y Isobe, et al. 2009 Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211 J Clin Oncol 27 5594 5600 1:CAS:528:DC%2BC3cXhtVWit7s%3D 19805668 10.1200/JCO.2009.23.8295
28. SJ Kim K Kim BS Kim CY Kim C Suh J Huh, et al. 2009 Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-cell lymphoma: Consortium for Improving Survival of Lymphoma Study J Clin Oncol 27 6027 6032 1:CAS:528:DC%2BC3cXhtVWisLk%3D 19884539 10.1200/JCO.2009.23.8592
29. M Ando K Sugimoto T Kitoh M Sasaki K Mukai J Ando, et al. 2005 Selective apoptosis of natural killer-cell tumours by l-asparaginase Br J Haematol 130 860 868 1:CAS:528:DC%2BD2MXhtFegtLzF 16156856 10.1111/j.1365-2141.2005.05694.x
30. W Yong W Zheng J Zhu Y Zhang X Wang Y Xie, et al. 2008 l-Asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type Ann Hematol 88 647 652 19107482 10.1007/s00277-008-0669-3
31. Jaccard A, Gachard N, Coppo P, Morschhauser F, Galicier L, Ysebaert L, et al. A prospective phase II trial of an l-asparaginase containing regimen in patients with refractory or relapsing extra nodal NKJT-cell lymphoma. Blood. 2008;112(11):217.
32. WS Koom EJ Chung WI Yang SJ Shim CO Suh JK Roh, et al. 2004 Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints Int J Radiat Oncol Biol Phys 59 1127 1137 15234048 10.1016/j.ijrobp.2003.12.006
33. K Sakata N Fuwa T Kodaira K Aratani H Ikeda M Takagi, et al. 2006 Analyses of dose-response in radiotherapy for patients with mature T/NK-cell lymphomas according to the WHO classification Radiother Oncol 79 179 184 16644044 10.1016/j.radonc.2006.03.014
34. J Lee C Suh YH Park YH Ko SM Bang JH Lee, et al. 2006 Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study J Clin Oncol 24 612 618 16380410 10.1200/JCO.2005.04.1384
35. TM Kim YH Park SY Lee JH Kim DW Kim SA Im, et al. 2005 Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type Blood 106 3785 3790 1:CAS:528:DC%2BD2MXht12ksbbN 16109779 10.1182/blood-2005-05-2056
36. SJ Kim BS Kim CW Choi J Choi I Kim YH Lee, et al. 2007 Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type Ann Oncol 18 1382 1387 1:STN:280:DC%2BD2svnsFSisw%3D%3D 17693651 10.1093/annonc/mdm183
37. WY Au A Pang C Choy CS Chim YL Kwong 2004 Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients Blood 104 243 249 1:CAS:528:DC%2BD2cXlslWgsb0%3D 15031209 10.1182/blood-2003-12-4197
38. WY Au AK Lie R Liang YL Kwong CC Yau MM Cheung, et al. 2003 Autologous stem cell transplantation for nasal NK/T-cell lymphoma: a progress report on its value Ann Oncol 14 1673 1676 1:STN:280:DC%2BD3srgtlWquw%3D%3D 14581277 10.1093/annonc/mdg458
39. HJ Kim SM Bang J Lee HC Kwon C Suh JH Lee, et al. 2006 High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases Bone Marrow Transplant 37 819 824 1:CAS:528:DC%2BD28XjsFaku78%3D 16547486 10.1038/sj.bmt.1705349
40. J Lee WY Au MJ Park J Suzumiya S Nakamura J Kameoka, et al. 2008 Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study Biol Blood Marrow Transplant 14 1356 1364 19041057 10.1016/j.bbmt.2008.09.014
41. MM Cheung JK Chan WH Lau W Foo PT Chan CS Ng, et al. 1998 Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients J Clin Oncol 16 70 77 1:STN:280:DyaK1c7gtFKktw%3D%3D 9440725
42. I Cuadra-Garcia GM Proulx CL Wu CC Wang BZ Pilch NL Harris, et al. 1999 Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital Am J Surg Pathol 23 1356 1369 1:STN:280:DC%2BD3c%2FitFCktw%3D%3D 10555004 10.1097/00000478-199911000-00006
43. GE Kim WS Koom WI Yang SW Lee KC Keum CG Lee, et al. 2004 Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis Head Neck 26 584 593 15229900 10.1002/hed.20015
44. Kim SJ, Oh SY, Hong JY, Chang MH, Lee DH, Huh J, et al. When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type? Ann Oncol 21:1058-63.
45. JK Chan VC Sin KF Wong CS Ng WY Tsang CH Chan, et al. 1997 Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm Blood 89 4501 4513 1:CAS:528:DyaK2sXjvFCksbY%3D 9192774
46. ST Lim SW Hee R Quek LC Lim SP Yap EL Loong, et al. 2008 Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis Eur J Haematol 80 55 60 18028433